CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives


Autoria(s): Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew
Data(s)

01/05/2014

Formato

application/pdf

Identificador

http://boris.unibe.ch/66977/1/CD62L%20%28L-Selectin%29%20Shedding.pdf

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (May 2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology, 146(5), p. 239. Elsevier

doi:10.7892/boris.66977

urn:issn:0016-5085

Idioma(s)

eng

Publicador

Elsevier

Relação

http://boris.unibe.ch/66977/

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (May 2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology, 146(5), p. 239. Elsevier

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/conferenceObject

info:eu-repo/semantics/publishedVersion

PeerReviewed